 |
GEMoaB
Last updated: October 12, 2024
Michael Pehl, CEO
Germany | Funding: $250M (+)
Website: https://www.gemoab.com
GEMoaB develops universal CAR-T platform with focus on providing significantly safer and more efficacious treatments to patients who are suffering from hard-to-treat cancers and autoimmune diseases
Website: https://www.gemoab.com
GEMoaB develops universal CAR-T platform with focus on providing significantly safer and more efficacious treatments to patients who are suffering from hard-to-treat cancers and autoimmune diseases
